Revisiting checkpoint inhibitors for myeloma: maintenance after stem cell transplant

Multiple myeloma is a hematologic malignancy of plasma cells that manifests with bone marrow tumors causing lytic bone lesions. Autologous stem cell transplantation (ASCT) after high-dose chemotherapy and followed by prolonged maintenance therapy with lenalidomide (LEN) is an effective standard-of-c...

Descripción completa

Detalles Bibliográficos
Autores principales: Meermeier, Erin W., Bergsagel, P. Leif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927926/
https://www.ncbi.nlm.nih.gov/pubmed/36787254
http://dx.doi.org/10.1172/JCI167346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927926/
https://www.ncbi.nlm.nih.gov/pubmed/36787254
http://dx.doi.org/10.1172/JCI167346

Ejemplares similares